Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about APLS

Recent news which mentions APLS

< Previous 1 2 3 4 5 6 7 8 9 Next >

Investigator Says Apellis' Lead Product Shows 'First Direct Evidence Of Slowing Geographic Atrophy Lesion Growth'

October 03, 2022

10 Health Care Stocks Whale Activity In Today's Session

September 29, 2022

Where Apellis Pharmaceuticals Stands With Analysts

September 08, 2022

Stifel Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know

September 08, 2022

Moderna To $165? Plus This Analyst Cuts PT On FedEx

September 08, 2022

Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday

August 25, 2022

Advance Auto Parts, Nordstrom And Other Big Stocks Recording Losses On Wednesday

August 25, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

August 24, 2022

Apellis Shares Show Mixed Reaction After Positive 2 Years Data From Late-Stage Retinal Disorder Study

August 24, 2022

Apellis's Pegcetacoplan Shows Increased Effects In Geographic Atrophy At Two Years

August 24, 2022

Where Apellis Pharmaceuticals Stands With Analysts

August 09, 2022

7 Cheap Biotech Stocks to Buy Now

August 03, 2022

Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday

July 20, 2022

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary

July 19, 2022

Nasdaq Rises More Than 300 Points; Crude Oil Moves Higher

July 19, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

July 19, 2022

HC Wainwright Initiates Coverage On Upcoming Complement Franchise Company Apellis Pharmaceuticals

July 19, 2022

Dow Surges 500 Points; Johnson & Johnson Lowers Guidance

July 19, 2022

This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session

July 19, 2022

Why U.S. Stocks Are Trading Higher; Housing Starts Drop Further In June

July 19, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2022

July 19, 2022

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

July 19, 2022

Why Apellis Pharmaceuticals Stock Is Soaring

July 19, 2022

Apellis Shares Climb As FDA Accepts Geographic Atrophy Candidate Submission Under Priority Review

July 19, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

July 19, 2022

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

June 22, 2022

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data

June 08, 2022

Apellis Begins Paitent Dosing In Late-Stage Study Of Rare Kidney Disease Candidate

June 07, 2022

Expert Ratings for Apellis Pharmaceuticals

May 24, 2022

Goldman Sachs Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know

May 24, 2022

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.